Rezultati - Puyuan Xing

ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer od Dantong Sun, Fei Teng, Puyuan Xing, Junling Li

Connect to this object online.

EGFR uncommon alterations in advanced non-small cell lung cancer and structural insights into sensitivity to diverse tyrosine kinase inhibitors od Haiyan Xu, Guangjian Yang, Runze Liu, Yaning Yang, Weihua Li, Junling Li, Xuezhi Hao, Puyuan Xing, Yan Wang

Connect to this object online.

Multi-dimensional characterization of immunological profiles in small cell lung cancer uncovers clinically relevant immune subtypes with distinct prognoses and therapeutic vulnerab... od Lin Yang, Zicheng Zhang, Jiyan Dong, Yibo Zhang, Zijian Yang, Yiying Guo, Xujie Sun, Junling Li, Puyuan Xing, Jianming Ying, Meng Zhou

Connect to this object online.